On December 16, 2025, Nuo Therapeutics, Inc. held its Annual Meeting where shareholders elected four directors, ratified the accounting firm MaloneBailey LLP, and approved executive compensation, with significant support in each vote. The election results included votes like 33,688,602 for David E. Jorden and 35,917,807 for ratifying the accounting firm.